| Dr Pamela Hilary Kasenetz, MD | |
|
2800 S Shirlington Rd, Ste 410, Arlington, VA 22206-3601 | |
| (703) 533-2222 | |
| (703) 533-3421 |
| Full Name | Dr Pamela Hilary Kasenetz |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 16 Years |
| Location | 2800 S Shirlington Rd, Arlington, Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649434556 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 0116020354 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Virginia Hospital Center | Arlington, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Arlington Medical Associates Pllc | 9335428630 | 3 |
News Archive
Advanced Cell Technology, Inc., a leader in the field of regenerative medicine, announced today first quarter financial results for the period ended March 31, 2011. The Company reported a loss from operations of $(4.8) million compared to a loss from operations of $(15.0) million in the 2010 first quarter.
Biogen Idec Inc. (NASDAQ:BIIB) announced today that FBC Acquisition Corp., its wholly owned subsidiary, has commenced a tender offer to acquire all of the outstanding shares of Facet Biotech Corporation (NASDAQ:FACT) for $14.50 per share in cash, in furtherance of its previously announced acquisition proposal. The tender offer is scheduled to expire at 12:00 midnight, ET, on October 19, 2009, unless extended or terminated.
One of the major reasons that treatment for HIV/AIDS often doesn't work as well as it should is resistance to the drugs involved. Now, scientists at McGill University have revealed how mutations hidden in previously ignored parts of the HIV genome play an important role in the development of drug resistance in AIDS patients. Their study will be published Aug. 8 in the Journal of Biological Chemistry.
The new collaborative research agreement between Human Longevity Inc. and the University of California, San Diego, announced today, represents a significant and necessary step in efforts to research and translate the potential of the human genome into novel and real treatments and therapies able to change and improve the human condition.
Some 50,000 people in the U.S. are diagnosed with Parkinson's disease (PD) every year. The American Institute of Neurology estimates there are one million people affected with this neurodegenerative disorder, with 60 years as the average age of onset.
› Verified 5 days ago
| Entity Name | Arlington Medical Associates Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578910337 PECOS PAC ID: 9335428630 Enrollment ID: O20161109000524 |
News Archive
Advanced Cell Technology, Inc., a leader in the field of regenerative medicine, announced today first quarter financial results for the period ended March 31, 2011. The Company reported a loss from operations of $(4.8) million compared to a loss from operations of $(15.0) million in the 2010 first quarter.
Biogen Idec Inc. (NASDAQ:BIIB) announced today that FBC Acquisition Corp., its wholly owned subsidiary, has commenced a tender offer to acquire all of the outstanding shares of Facet Biotech Corporation (NASDAQ:FACT) for $14.50 per share in cash, in furtherance of its previously announced acquisition proposal. The tender offer is scheduled to expire at 12:00 midnight, ET, on October 19, 2009, unless extended or terminated.
One of the major reasons that treatment for HIV/AIDS often doesn't work as well as it should is resistance to the drugs involved. Now, scientists at McGill University have revealed how mutations hidden in previously ignored parts of the HIV genome play an important role in the development of drug resistance in AIDS patients. Their study will be published Aug. 8 in the Journal of Biological Chemistry.
The new collaborative research agreement between Human Longevity Inc. and the University of California, San Diego, announced today, represents a significant and necessary step in efforts to research and translate the potential of the human genome into novel and real treatments and therapies able to change and improve the human condition.
Some 50,000 people in the U.S. are diagnosed with Parkinson's disease (PD) every year. The American Institute of Neurology estimates there are one million people affected with this neurodegenerative disorder, with 60 years as the average age of onset.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Pamela Hilary Kasenetz, MD 2800 S Shirlington Rd, Ste 410, Arlington, VA 22206-3601 Ph: (703) 533-2222 | Dr Pamela Hilary Kasenetz, MD 2800 S Shirlington Rd, Ste 410, Arlington, VA 22206-3601 Ph: (703) 533-2222 |
News Archive
Advanced Cell Technology, Inc., a leader in the field of regenerative medicine, announced today first quarter financial results for the period ended March 31, 2011. The Company reported a loss from operations of $(4.8) million compared to a loss from operations of $(15.0) million in the 2010 first quarter.
Biogen Idec Inc. (NASDAQ:BIIB) announced today that FBC Acquisition Corp., its wholly owned subsidiary, has commenced a tender offer to acquire all of the outstanding shares of Facet Biotech Corporation (NASDAQ:FACT) for $14.50 per share in cash, in furtherance of its previously announced acquisition proposal. The tender offer is scheduled to expire at 12:00 midnight, ET, on October 19, 2009, unless extended or terminated.
One of the major reasons that treatment for HIV/AIDS often doesn't work as well as it should is resistance to the drugs involved. Now, scientists at McGill University have revealed how mutations hidden in previously ignored parts of the HIV genome play an important role in the development of drug resistance in AIDS patients. Their study will be published Aug. 8 in the Journal of Biological Chemistry.
The new collaborative research agreement between Human Longevity Inc. and the University of California, San Diego, announced today, represents a significant and necessary step in efforts to research and translate the potential of the human genome into novel and real treatments and therapies able to change and improve the human condition.
Some 50,000 people in the U.S. are diagnosed with Parkinson's disease (PD) every year. The American Institute of Neurology estimates there are one million people affected with this neurodegenerative disorder, with 60 years as the average age of onset.
› Verified 5 days ago
Dr. Alvaro Andres Puig Rodriguez, M.D Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1625 N George Mason Dr Ste 425, Arlington, VA 22205 Phone: 703-717-4400 | |
Tiffany C Turner, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1625 N George Mason Dr Ste 345, Arlington, VA 22205 Phone: 703-717-4400 Fax: 703-717-4401 | |
Dr. Anne Ruggles Pariser, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 2921 11th St S, Arlington, VA 22204 Phone: 703-979-1400 | |
Dr. Michael Andrew Cole, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1701 N George Mason Dr, Intensive Care Unit, Arlington, VA 22205 Phone: 571-244-8410 | |
Robert Paul Holman, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 1635 N George Mason Dr, Suite 180, Arlington, VA 22205 Phone: 703-276-7798 Fax: 703-276-0433 | |
Dr. Irmindra S Rana, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 611 S Carlin Springs Rd, Suite 301, Arlington, VA 22204 Phone: 703-998-0480 Fax: 703-379-0449 | |
Dr. Ashok Chauhan, M.D., Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 611 S Carlin Springs Rd, Suite 511, Arlington, VA 22204 Phone: 703-379-4446 Fax: 703-379-0449 |